![]() ![]() ![]() This combination unites two technology and service companies focused on serving health care. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone. To read this article on click here.Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Ligand Pharmaceuticals Incorporated (LGND) : Free Stock Analysis Report Masimo Corporation (MASI) : Free Stock Analysis Report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis ReportĪmedisys, Inc. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. However, Ligand Pharmaceuticals stock has declined 17.4% in the same time frame. Shares of Masimo have gained 16.6% in a year. The consensus mark for MASI’s 2023 earnings has moved 0.2% north in the past 30 days. The Zacks Consensus Estimate for MASI’s 2023 earnings indicates a rise of 3.7%, while the same for revenues suggests an improvement of 19.7% from the respective prior-year tallies. The bottom line of Masimo beat estimates in each of the trailing four quarters, the average beat being 10%. The consensus mark for LGND’s 2023 earnings has moved 26.2% north in the past 30 days. The Zacks Consensus Estimate for LGND’s 2023 earnings indicates a rise of 9.6% from the year-ago actuals. Ligand Pharmaceuticals’ earnings surpassed estimates in two of the last four quarters and missed the mark twice, the average surprise being 21.50%. Shares of UnitedHealth Group have gained 1.1% in the past month compared with the industry’s growth of 0.5%. The company expects to witness continuous growth in value-based care in the future. The physicians prefer value-based care as they are able to understand, diagnose and treat patients through the full cycle rather than a fee-based service. ![]() This growth is fueled by the growing popularity of value-based care for physicians. This highlights UNH’s unwavering focus on improving customer experience and providing better health outcomes. ![]() The company expects to serve more than 4 million patients in value-based care arrangements through Optum in 2023. The company expects to secure approval for the collaboration as no single participant holds more than a single-digit share in this space. UnitedHealth’s offer to combine with Amedisys comes in a bid to tap the growth opportunities as demand for in-home care exceeds the available supply. Each sub-segment of Optum is expected to deliver a solid performance, driving the overall segment’s growth. The primary growth drivers for Optum are pharmacy care services, care delivery, technology, government services and international portfolio. Optum contributed 38% to total first-quarter 2023 revenues. Moreover, the company can get access to Amedisys’ medicare customers, boosting its UnitedHealthcare business in the future. Better health outcomes at lower costs will drive Optum’s top line in the future. This move will combine Optum’s deep expertise in value-based care with Amedisys’ care and quality innovation within the home. People now seek treatment from the comforts of their homes. UnitedHealth has offered $100 per Amedisys share, implying a 26% premium on AMED’s most recent share price.Įver since the pandemic hit the world, demand for in-house care has risen. AMED, a pioneer of home health, high-acuity care and hospice. UnitedHealth Group Incorporated UNH unit, Optum, recently submitted a full-cash proposal to combine with Amedisys, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |